BK2246 Healthcare Plans
- 1772.203
- +9.763+0.55%
Analysts Offer Insights on Healthcare Companies: Herbalife (HLF), Alignment Healthcare (ALHC) and Vaxcyte (PCVX)
Humana: Hold Rating Amid Short-Term Pressures and Long-Term Optimism
Buy Rating Affirmed: CVS Health's Proactive Strategies Counter Medicare Advantage Pressures and Unlock Growth Opportunities
Marpai's Strategic Turnaround and Growth Potential Justify Buy Rating
Stephens Adjusts Price Target on UnitedHealth to $565 From $545
Bernstein Adjusts Price Target on Cigna to $411 From $389
Argus Research Sticks to Its Buy Rating for CVS Health (CVS)
Analysts Are Bullish on These Healthcare Stocks: IQVIA Holdings (IQV), CVS Health (CVS)
Argus Research Maintains Buy on CVS Health, Lowers Price Target to $80
CVS Health Analyst Ratings
Argus Research Adjusts Price Target on CVS Health to $80 From $100
Clover Health's Positive Trajectory: A Buy Rating With a Focus on Sustained Profitability
Alignment Healthcare Analyst Ratings
Piper Sandler Upgrades Alignment Healthcare to Overweight, Raises Price Target to $8
Analysts Offer Insights on Healthcare Companies: Clover Health Investments (CLOV), Cogent Biosciences (COGT) and Adaptive Biotechnologies (ADPT)
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Crinetics Pharmaceuticals (CRNX) and Alignment Healthcare (ALHC)
CVS Health Analyst Ratings
Wells Fargo Adjusts CVS Health's Price Target to $60 From $76
CVS Health Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Alignment Healthcare (ALHC), Butterfly Network (BFLY) and Deciphera Pharmaceuticals (DCPH)